Form D Explorer

Inspect source fieldsReport a record issue

Form D/A — GT Biotech Fund, LP

0000905148-25-002582 · filed Jul 29, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings

Offering

Industry
Pooled Investment Fund
Reported offering amount
—
Reported amount sold
$229,257,953
Minimum investment
$16,000
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
GT Biotech Fund, LP
CIK
1806841
Entity
Limited Partnership
Jurisdiction
DELAWARE
Year incorporated
—
Address
40 S. Main Street
Memphis, Tennessee 38103
Phone
901-526-9750

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗